Replies to post #94318 on Biotech Values

[randychub]

"these sales reps will need all the help they can get because Tarceva’s efficacy in the maintenance setting was marginal"

If you where a patient in this setting would you take it? I would if it didn't cost me a boat load of money.

Do sales reps have that much of an impact with oncologists? Most of those I know are very well informed.

Thanks

Randy

[srsmgja]

Anyone have thoughts as to what this new approval will do for OSIP and the current hostile bid??